Double-Blind, Alacramyn® vs. Placebo in Pediatric Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

August 31, 2005

Study Completion Date

October 31, 2005

Conditions
Scorpion Sting Envenomation
Interventions
BIOLOGICAL

Antivenin Centruroides (scorpion) equine immune F(ab)2

3 vials of Alacramyn reconstitued in 50 ml of normal saline as a IV infusion over 10 minutes.

OTHER

Placebo

Placebo reconstituted in 50 ml of normal saline administered over 10 min

Trial Locations (2)

85712

Tucson Medical Center, Tucson

85724

University Medical Center, Tucson

All Listed Sponsors
collaborator

University of Arizona

OTHER

collaborator

Universidad Nacional Autonoma de Mexico

OTHER

lead

Instituto Bioclon S.A. de C.V.

INDUSTRY

NCT00685230 - Double-Blind, Alacramyn® vs. Placebo in Pediatric Patients | Biotech Hunter | Biotech Hunter